You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

Article info

Article menu

Download PDFPDF

Short Report
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

Authors

  • Evan J Lipson Department of OncologyJohns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center Baltimore MD USA PubMed articlesGoogle scholar articles
  • Victor E Velculescu Department of OncologyJohns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center Baltimore MD USA PubMed articlesGoogle scholar articles
  • Theresa S Pritchard Department of SurgeryJohns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center Baltimore MD USA PubMed articlesGoogle scholar articles
  • Mark Sausen Personal Genome Diagnostics Baltimore MD USA PubMed articlesGoogle scholar articles
  • Drew M Pardoll Department of OncologyJohns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center Baltimore MD USA PubMed articlesGoogle scholar articles
  • Suzanne L Topalian Department of SurgeryJohns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center Baltimore MD USA PubMed articlesGoogle scholar articles
  • Luis A Diaz Department of OncologyJohns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center Baltimore MD USA Ludwig Center for Cancer Genetics and Therapeutics and the Swim Across America LaboratoryJohns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center Baltimore MD USA PubMed articlesGoogle scholar articles

Citation

Lipson EJ, Velculescu VE, Pritchard TS, et al
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
Journal for ImmunoTherapy of Cancer 2014;2:42. doi: 10.1186/s40425-014-0042-0
Online issue publication 
February 08, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.